Increased mRNA expression of epidermal growth factor receptor, human epidermal receptor, and survivin in human gastric cancer after the surgical stress of laparotomy versus carbon dioxide pneumoperitoneum in a murine model-Reference-Cited by-同舟云学术

Increased mRNA expression of epidermal growth factor receptor, human epidermal receptor, and survivin in human gastric cancer after the surgical stress of laparotomy versus carbon dioxide pneumoperitoneum in a murine model

Published:2009-12-30 Issue:6 Volume:24 Page:1427-1433
ISSN:0930-2794
Container-title:Surgical Endoscopy
language:en
Short-container-title:Surg Endosc

Author:

Amin Anwar Tawfik,Shiraishi Norio,Ninomiya Shigeo,Tajima Masaaki,Inomata Masafumi,Kitano Seigo

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00464-009-0793-8.pdf

Reference35 articles.

1. Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH (1998) Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 228:347–354

2. Han SW, Oh DY, Im SA, Park SR, Lee KW, Song HS, Lee NS, Lee KH, Choi IS, Lee MH, Kim MA, Kim WH, Bang YJ, Kim TY (2009) Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer. Br J Cancer 100:298–304

3. Asanuma H, Torigoe T, Kamiguchi K, Hirohashi Y, Ohmura T, Hirata K, Sato M, Sato N (2005) Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res 65:11018–11025

4. Jonker DJ, O’Callaghan CJ, Karapetis Cs, Zalcberg JR, Tu D, Au HJ, Berry SR, Krahn M, Price T, Simes RJ, Tebbutt NC, vanHazel G, Wiezbicki R, Langer C, Moore MJ (2007) Cetuximab for the treatment of colorectal cancer. N Engl J Med 357:2040–2048

5. Pinto C, Di Fabio F, Siena S, Cascinu S, Rojas Llimpe FL, Ceccarelli C, Mutri V, Gianetta L, Giaquinta S, Funaioli C, Berardi R, Longobardi C, Piana E, Martoni AA (2007) Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FULCETUX study). Ann Oncol 18:510–517

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of interval between primary cytoreductive surgery with bowel resection and initiation of adjuvant chemotherapy on survival of women with advanced ovarian cancer: a multicenter cohort study;Journal of Gynecologic Oncology;2022

2. Surgical trauma‐induced CCL18 promotes recruitment of regulatory T cells and colon cancer progression;Journal of Cellular Physiology;2018-09-14

3. Surgical trauma contributes to progression of colon cancer by downregulating CXCL4 and recruiting MDSCs;Experimental Cell Research;2018-09

4. Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model;Journal of Ovarian Research;2018-07-04

5. Regulating surgical oncotaxis to improve the outcomes in cancer patients;Surgery Today;2013-06-05